Skip to content

NioCorp Developments Ltd. NB Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

Nuvation Bio logo
Nuvation BioNUVB
5.8M0.0%
KEE
Keel Infrastructure Corp. Common StockKEEL
2.2M
Unusual Machines logo
Unusual MachinesUMAC
0-100%
KRAKacquisition
 logo
KRAKacquisition KRAQ
0
The RealReal logo
The RealRealREAL
7.9M
NuScale Power logo
NuScale PowerSMR
0-100%

Other financials

Income statement

See full
Net income$669.0K+113%
EPS (diluted)$0.01+109%

Balance sheet

See full
Cash & equivalents$421.3M+32,455%
Total debt$379.0K+153%
Total equity$435.4M+5,681%
Total assets$469.0M+2,439%

Cash flow

See full
Operating cash flow-$4.4M-12.5%

Valuation

See full
Market cap$669.7M+362%
Enterprise value$248.82M+73.2%

Returns & leverage

See full
Return on equity-24.1%
Debt / equity0.0×
Current ratio31.1×+29.9×

Where this comes from

Reported directly by NioCorp Developments Ltd. in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: NioCorp Developments Ltd.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about NioCorp Developments Ltd.'s warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NioCorp Developments Ltd.'s warrants and rights outstanding?
NioCorp Developments Ltd. (NB) reported warrants and rights outstanding of 19.1M in Q1 2026.
How has NioCorp Developments Ltd.'s warrants and rights outstanding changed year-over-year?
NioCorp Developments Ltd.'s warrants and rights outstanding decreased by 35.3% year-over-year, from 29.5M to 19.1M.
What is the long-term trend for NioCorp Developments Ltd.'s warrants and rights outstanding?
Over 4 years (2021 to 2025), NioCorp Developments Ltd.'s warrants and rights outstanding has grown at a 113.8% compound annual growth rate (CAGR), from 1.4M to 30M.
What does warrants and rights outstanding mean?
Represents the total number or value of derivative instruments that grant holders the right to purchase company equity at a specified price. This metric is a primary indicator of potential future equity dilution and the overhang of securities that could impact share price performance. It is essential for calculating fully diluted share counts and understanding long-term capital structure impacts.